KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Equity (2016 - 2025)

Historic Return on Equity for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to 0.01%.

  • TherapeuticsMD's Return on Equity fell 200.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.0% for FY2024, which is 800.0% up from last year.
  • TherapeuticsMD's Return on Equity amounted to 0.01% in Q3 2025, which was down 200.0% from 0.0% recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Return on Equity registered a high of 5.35% during Q2 2021, and its lowest value of 16.9% during Q4 2022.
  • Its 5-year average for Return on Equity is 0.19%, with a median of 0.01% in 2025.
  • In the last 5 years, TherapeuticsMD's Return on Equity crashed by -179500bps in 2022 and then skyrocketed by 168100bps in 2023.
  • TherapeuticsMD's Return on Equity (Quarter) stood at 1.05% in 2021, then tumbled by -1709bps to 16.9% in 2022, then soared by 99bps to 0.09% in 2023, then soared by 105bps to 0.0% in 2024, then soared by 74bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q3 2025, 0.0% for Q2 2025, and 0.0% during Q1 2025.